Literature DB >> 11676531

Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities.

F Kopp1, B Dahlmann, L Kuehn.   

Abstract

The activity of the proteasome, the major non-lysosomal proteinase in eukaryotes, is stimulated by two activator complexes, PA700 and PA28. PA700-20 S-PA700 proteasome complexes, generally designated as 26 S proteasomes, degrade proteins, whereas complexes of the type PA28-20 S-PA28 degrade only peptides. We report, for the first time, the in vitro reconstitution of previously identified hybrid proteasomes (PA700-20 S-PA28) from purified PA700-20 S proteasome complexes and PA28 activator. In electron micrographs, the hybrid appears as a corkscrew-shaped particle with a PA700 and a PA28 activator each bound to a terminal alpha-disk of the 20 S core proteasome. The multiple peptidase activities of hybrid proteasomes are not different from those of PA28-20 S-PA28 or PA700-20 S-PA700 complexes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676531     DOI: 10.1006/jmbi.2001.5063

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Blm10 protein promotes proteasomal substrate turnover by an active gating mechanism.

Authors:  Thomas Dange; David Smith; Tahel Noy; Philipp C Rommel; Lukas Jurzitza; Radames J B Cordero; Anne Legendre; Daniel Finley; Alfred L Goldberg; Marion Schmidt
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 2.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

3.  Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. Insights into the mechanism of activation of mature yeast proteasomes.

Authors:  Jack Iwanczyk; Kianoush Sadre-Bazzaz; Katherine Ferrell; Elena Kondrashkina; Timothy Formosa; Christopher P Hill; Joaquin Ortega
Journal:  J Mol Biol       Date:  2006-08-09       Impact factor: 5.469

4.  Global organization and function of mammalian cytosolic proteasome pools: Implications for PA28 and 19S regulatory complexes.

Authors:  Toru Shibatani; Eric J Carlson; Fredrick Larabee; Ashley L McCormack; Klaus Früh; William R Skach
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

5.  Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome.

Authors:  Dawadschargal Bech-Otschir; Annett Helfrich; Cordula Enenkel; Gesa Consiglieri; Michael Seeger; Hermann-Georg Holzhütter; Burkhardt Dahlmann; Peter-Michael Kloetzel
Journal:  Nat Struct Mol Biol       Date:  2009-01-25       Impact factor: 15.369

6.  Proteasome activity or expression is not altered by activation of the heat shock transcription factor Hsf1 in cultured fibroblasts or myoblasts.

Authors:  David M Taylor; Edor Kabashi; Jeffrey N Agar; Sandra Minotti; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

Review 7.  Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.

Authors:  Rachel Raynes; Laura C D Pomatto; Kelvin J A Davies
Journal:  Mol Aspects Med       Date:  2016-05-04

8.  Immunoproteasome Activation During Early Antiviral Response in Mouse Pancreatic β-cells: New Insights into Auto-antigen Generation in Type I Diabetes?

Authors:  Wieke Freudenburg; Madhav Gautam; Pradipta Chakraborty; Jared James; Jennifer Richards; Alison S Salvatori; Aaron Baldwin; Jill Schriewer; R Mark L Buller; John A Corbett; Dorota Skowyra
Journal:  J Clin Cell Immunol       Date:  2013-04-23

9.  DynaMod: dynamic functional modularity analysis.

Authors:  Choong-Hyun Sun; Taeho Hwang; Kimin Oh; Gwan-Su Yi
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

Review 10.  Linkage between the proteasome pathway and neurodegenerative diseases and aging.

Authors:  Sophie Vigouroux; Marièle Briand; Yves Briand
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.